Table sugar could hold a cheaper, quicker key to making vital drugs

Jun, Mon, 2026
Innova1
Purchase & Order

Pioneering research has developed a new way of creating carbohydrate-based medicines that could ultimately replace costly drugs for common health conditions, using two cheap basic ingredients—table sugar and vinegar.

Table sugar could hold a cheaper, quicker key to making vital drugs
Pioneering research has developed a new way of creating carbohydrate-based medicines that could ultimately replace costly drugs for common health conditions, using two cheap basic ingredients—table sugar and vinegar.
Light-activated compound kills antibiotic-resistant bacteria by turning its own defense enzyme against it
Antibiotic resistance is becoming an accelerating crisis because of the overuse and misuse of antibiotics over many years. The problem is exacerbated when antibiotics wipe out susceptible bacteria but leave resistant bacteria behind to multiply, further spreading resistance. There is an ongoing search for new treatments to fight resistant bacteria, and now researchers may have found a way to successfully treat at least one type of resistant bacteria.
Injectable silk-kudzu hydrogel achieves complete wound closure in laboratory tests
Researchers at the Terasaki Institute for Biomedical Innovation have developed an injectable hydrogel, a water-based gel material, made from silk proteins and a plant-derived compound. In laboratory tests, the material promoted complete wound closure within 72 hours, suggesting a potential new approach to minimally invasive soft tissue repair.
New workflow transforms nonfunctional protein scaffolds into active enzymes
Enzymes are regarded as the key to sustainable chemistry. Despite major advances in protein design, creating artificial enzymes from scratch has so far remained a grand challenge. A research team at the University of Bayreuth, in collaboration with scientists from the University of Ottawa, has now demonstrated how nonfunctional protein scaffolds can be transformed into highly active enzymes. The researchers report their findings in Nature Chemical Biology.
Researchers develop a new prodrug and localized drug delivery platform for selective treatment of cancer
A new collaborative study reports the discovery and application of a novel therapeutic strategy to selectively target EGFR and other kinases with controlled release in tumor microenvironments to improve therapeutic efficacy, with promising results. The research is published in Bioorganic Chemistry.